AMENDMENT TO2020 Series a Preferred Stock Warrants • September 24th, 2020 • Immunome Inc. • Pharmaceutical preparations • Delaware
THIS AMENDMENT (this “Amendment”) is entered into effective as of September 20, 2020 by and among Immunome, Inc. (the “Company”), a Delaware corporation, and the undersigned holders of Warrants (defined below) (the “Holders”). This Amendment amends the 2020 Series A Preferred Stock Purchase Warrants issued pursuant to the 2020 Series A Preferred Stock Purchase Agreement dated as of June 2, 2020 among the Company and the purchasers who are parties thereto, as amended (the “Warrants”). All capitalized terms used in this Amendment without definition shall have the respective meanings assigned to them in the Warrants.
